COVID-19 Vaccine Types and How They Work
Modern COVID-19 vaccines fall into distinct categories, each triggering immunity through different mechanisms.
- mRNA vaccines (Pfizer-BioNTech, Moderna): These deliver genetic instructions that teach your cells to produce a harmless coronavirus protein. Your immune system recognises this protein as a threat and learns to destroy it. When exposed to the real virus, your body responds immediately with antibodies and T-cells.
- Viral vector vaccines (AstraZeneca, Sputnik V): A modified adenovirus carries genetic material into your cells, prompting them to manufacture the spike protein. Your immune system then mounts a defence against this protein, providing protection against future infection.
- Inactivated vaccines (Sinopharm): These use chemically weakened or killed virus particles, allowing your immune system to study the complete viral structure without risk of disease.
- Single-dose vaccines (Johnson & Johnson): This adenoviral vector approach achieves protective immunity after just one injection, though some people receive a booster.
Individual immune responses vary considerably. Factors including age, underlying health conditions, medication use, and prior infection history all influence how quickly and robustly you develop protection.
Immunity Timeline Formula
Full immunity emerges 14 days after your final dose across all major vaccine platforms. The specific date depends on your vaccination schedule and which vaccine you received. Use these formulas to calculate your protection milestone:
Pfizer/Moderna/AstraZeneca/Sinopharm/Sputnik V immunity = Second dose date + 14 days
Johnson & Johnson immunity = First dose date + 14 days
Half-immunity (detectable antibodies) = First dose date + 14 days (most vaccines)
AstraZeneca half-immunity = First dose date + 22 days
Sputnik V half-immunity = First dose date + 16 days
Second dose date— The calendar date you received your second vaccine injectionFirst dose date— The calendar date you received your initial vaccine injectionHalf-immunity— Partial but measurable immune protection from vaccine-induced antibodies
Understanding Vaccine Effectiveness
Vaccine effectiveness describes how well a vaccine prevents disease in real-world conditions. Researchers measure effectiveness in distinct ways:
- Symptomatic disease prevention: The vaccine reduces your chances of developing COVID-19 symptoms if exposed. You might still contract the virus, but without clinical illness.
- Documented infection prevention: The vaccine blocks infection entirely, preventing both viral replication and symptom development. This is the most stringent measure.
- Severe illness and hospitalisation prevention: Even if breakthrough infections occur, the vaccine significantly reduces hospitalisations and deaths.
Published trial data shows Pfizer and Moderna achieved approximately 95% effectiveness against symptomatic disease, while AstraZeneca demonstrated roughly 70–90% depending on dosing intervals. Johnson & Johnson reported approximately 66% effectiveness against symptomatic infection and 85% against severe disease. These figures represent average population responses; your individual protection may differ based on immune competence and variant prevalence.
Key Considerations When Tracking Immunity
Several important factors affect your actual immunity timeline and real-world protection.
- Variant and waning immunity matter — The formulas above reflect protection against the original strain. New variants may partially evade vaccine-induced immunity, reducing effectiveness over time. Booster shots are recommended as immunity wanes, typically 6–12 months after your primary series, to restore protection against circulating strains.
- Schedule adherence affects timelines — If your second dose falls outside the standard interval, your immunity date shifts accordingly. Longer intervals between doses (for AstraZeneca, 4–12 weeks) can actually enhance immune response, but also delay reaching peak protection. Always check with your healthcare provider about optimal spacing.
- Pre-existing immunity complicates calculations — If you had COVID-19 before vaccination, your immune system may mount faster, stronger responses. Hybrid immunity from previous infection plus vaccination provides more durable protection than vaccination alone, but this calculator assumes primary series response only.
- Side effects signal immune activation — Arm soreness, fever, and lymph node swelling are signs your immune system is responding vigorously. These common effects subside within 48 hours and do not delay immunity development. Paracetamol can ease discomfort, but consult a doctor if symptoms persist beyond three days.
Duration of Vaccine-Induced Immunity
How long does COVID-19 vaccine immunity last? The honest answer: we're still gathering data. Vaccinated individuals from the earliest clinical trials are now over two years post-vaccination, and protection remains demonstrable—though antibody levels decline gradually.
Current evidence suggests:
- 12 months of robust protection: Vaccine effectiveness against symptomatic and severe disease remains strong through the first year, even as antibody titres fall.
- Waning after 6 months: Some studies indicate reduced effectiveness against new variants around six months, prompting booster recommendations for high-risk groups.
- T-cell memory persists: Even when antibody levels drop, T-cells trained by vaccination continue recognising the virus for years, helping prevent severe disease.
- Ongoing surveillance: Public health agencies continue monitoring long-term outcomes in vaccinated populations to refine booster schedules and identify optimal re-vaccination intervals.
Boosters restore antibody levels and renew variant-specific protection, making them valuable for maintaining immunity against evolving strains, particularly for older adults and immunocompromised individuals.